GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer
Clinical trial NCT06994507 · RECRUITING
Trial details
- NCT number
- NCT06994507
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2026-09-01
- Enrollment
- 352
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.